ArticleSTAR protocols2021

Glioblastoma patient-derived cell-based phenotypic drug screening and identification of possible action mechanisms through proteomic analysis.

Young Eun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.